Some pharma industry executives have tried to blame pharmacy benefit managers for high drug prices, claiming that PBMs somehow force drugmakers to raise prices to get themselves bigger rebates. “This makes little sense since the groups that hire PBMs — not PBMs themselves — determine how these savings are applied, which is most often to reduce premiums and other costs,” writes Pharmaceutical Care Management Association President and CEO Mark Merritt.